시장보고서
상품코드
1149505

세계의 말초동맥질환 시장 예측 : 인사이트, 경쟁 상황, 시장(2027년)

Peripheral Artery Disease Market Insights, Competitive Landscape and, Market Forecast - 2027

발행일: | 리서치사: DelveInsight Business Research LLP | 페이지 정보: 영문 100 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 말초 동맥 질환 시장 규모는 2021년 36억 5,000만 달러가 되었습니다. 시장은 2022-2027년 예측 기간 동안 8.45% CAGR 확대되었으며, 2027년 59억 3,000만 달러에 달할 것으로 예측되고 있습니다. 시장은 고령자 인구 부담 증가나 전 세계의에서 말초동맥질환(PAD) 및 동맥경화 유병률 상승 등 요인에 의해 성장이 전망되고 있습니다.

세계의 말초동맥질환(Peripheral Artery Disease) 시장을 조사했으며 시장 주요 요약와 더불어 치료유형별, 최종 사용자별, 지역별 동향, 시장에 진입하는 기업 프로필 등을 제공합니다.

목차

제1장 말초동맥질환(PAD) 시장보고서 소개

제2장 말초동맥질환(PAD) 시장 주요 요약

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 말초동맥질환(PAD) 시장 주요 요인 분석

  • 말초동맥질환(PAD) 시장 촉진 요인
  • 말초동맥질환(PAD) 시장 억제 요인과 과제
  • 말초동맥질환(PAD) 시장 기회

제5장 말초동맥질환(PAD) 시장에 관한 포터의 5가지 경쟁요인 분석

제6장 말초동맥질환(PAD) 시장 COVID-19의 영향 분석

제7장 말초동맥질환(PAD) 시장 레이아웃

  • 치료 유형별
  • 최종 사용자별
  • 지역별
  • 북미

제8장 말초동맥질환(PAD) 시장 기업과 제품 프로필

  • Medtronic
  • Otivio.
  • Koninklijke Philips NV
  • B. Braun SE
  • Boston Scientific Corporation
  • BD.
  • Cook
  • Bayer AG
  • Terumo Europe NV
  • Biotronik
  • Cardinal Health.
  • Abbott.
  • AngioDynamics.
  • Cardiovascular Systems, Inc.
  • Biosensors International Group, Ltd.
  • Contego Medical, Inc.
  • Cordis.
  • Edwards Lifesciences Corporation.
  • Ra Medical Systems
  • REX MEDICAL

제10장 KOL 견해

제11장 프로젝트 접근

제12장 DelveInsight 정보

제13장 면책사항과 문의

NJH 22.11.18

PERIPHERAL ARTERY DISEASE (PAD) MARKET BY TREATMENT TYPE (DEVICES [ANGIOPLASTY BALLOON, ANGIOPLASTY STENTS, CATHETERS, PLAQUE MODIFICATION DEVICES, HEMODYNAMIC FLOW ALTERATION DEVICES, AND OTHERS], AND DRUGS), BY END-USER (HOSPITALS & CLINICS, AMBULATORY SURGICAL CENTERS, AND SPECIALTY CLINICS), AND BY GEOGRAPHY IS EXPECTED TO ADVANCE AT A RESPECTABLE CAGR FORECAST TILL 2027 OWING TO THE INCREASING NUMBER OF DISABILITY DUE TO THE FACTORS SUCH AS THE INCREASING PREVALENCE OF PERIPHERAL ARETERY DISEASES, AND ARTERIOSCLEROSIS, AND THE RISING GERIATRIC POPULATION BURDEN ACROSS THE GLOBE.

The global peripheral artery disease (PAD) market was valued at USD 3.65 billion in 2021, growing at a CAGR of 8.45% during the forecast period from 2022 to 2027 to reach USD 5.93 billion by 2027. The peripheral artery disease (PAD) market is observing a remarkable market growth due to the factors such as the escalating burden of geriatric population and the rising prevalence of peripheral artery disease (PAD) and arteriosclerosis across the globe. Further, the rising prevalence of obesity, diabetes, and high blood pressure, increasing product launches and approvals, presence of key players in the market, and others will create a necessity for the peripheral artery disease (PAD) in the market. Therefore, the market for peripheral artery disease (PAD) is estimated to grow at a substantial CAGR during the forecast period from 2022 to 2027.

PERIPHERAL ARTERY DISEASE (PAD) MARKET DYNAMICS:

One of the key factor influencing the growth of the peripheral artery disease in the market is the increasing prevalence of peripheral artery diseases (PAD) across the world.

For instance, as per Global Burden of Disease 2019, in 2019, there were 56.4 million prevalent cases of PAD among those aged 40-70, worldwide. According to the Centers for Disease Control and Prevention (CDC) 2021, it was estimated that approximately 6.5 million people age 40 and older in the United States had PAD, in 2021.

Further, PAD is primarily caused by the buildup of fatty plaque in the arteries, which is called atherosclerosis, thereby increasing prevalence of arteriosclerosis can ultimately increase the cases of PAD and further increasing the demand of PAD treatment devices and drugs in the market. For instance, as per the latest study conducted by Heart Research Institute, concluded that over the age of 40, people in general good health have about a 50% chance of developing serious atherosclerosis, with this risk increasing with age. Most people over the age of 60 have some atherosclerosis, but often do not have noticeable symptoms.

Thus, the increasing prevalence of various peripheral artery disease and arteriosclerosis will increase the demand of peripheral artery disease devices and drugs, thereby propelling the overall market growth.

Further, the increasing geriatric burden across the globe will aid in propelling the market of peripheral artery disease (PAD) during the study period (2022 - 2027). As per WHO 2022, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years, across the globe. The data provided by the above mentioned source estimated that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion, in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The number of persons aged 80 years or older was also provided by the same source, which is expected to triple between 2020 and 2050 to reach 426 million, globally. The increasing elderly population will increase the demand of peripheral artery disease (PAD) drugs and treatment devices as they are more prone to peripheral artery diseases, thereby increasing the overall market growth of the peripheral artery disease (PAD).

Additionally, the increasing rising prevalence of obesity, diabetes, and high blood pressure will increase the risk of peripheral artery disease, thereby increasing the demand of its treatment devices and drugs.

Therefore, the factors stated above collectively will drive the overall peripheral artery disease (PAD) market during the forecast period from 2022-2027.

However, the high cost of different devices, adverse events related to various treatments, and others may prove to be challenging factors for peripheral artery disease (PAD) market growth.

The peripheral artery disease (PAD) market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, stroke, and others. This resulted in the reduced number patients of routine treatments of the above mentioned disorders. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions in supply chain, raw materials, and other resources halted the manufacturing of devices and drugs, leading to the shortage of treatment devices and drugs in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, with the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatients visits and surgeries for the treatment of afore-mentioned ailments, thereby bringing the demand for products on track in the peripheral artery disease (PAD) market.

PERIPHERAL ARTERY DISEASE (PAD) MARKET SEGMENT ANALYSIS:

Peripheral Artery Disease (PAD) Market by Treatment Type (Devices [Angioplasty Balloon, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others], and Drugs), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the treatment type segment of the peripheral artery disease (PAD) market, the angioplasty balloon segment is expected to have a significant revenue share in the year 2021. This was primarily owing to the rising focus of manufacturers towards developing technologically advanced angioplasty balloon for an improved and efficient removal of clots and plaques and the various advantages offered by the category.

Moreover, the angioplasty balloon is a minimally invasive vascular procedure to open narrowed or blocked arteries in patients with peripheral arterial disease.

The angioplasty balloon can also relieve intermittent claudication in lesser time, which is a symptom of peripheral arterial disease.

Additionally, it is the most effective method for the widening of larger arteries, arteries with short blocked areas, or arteries that are narrowed and not blocked.

Further, the increasing product launches and regulatory approvals of angioplasty balloon, will aid in increasing its demand in the market. For instance, in June 2020, the US Food and Drug Administration (FDA) has cleared INFINITY Angioplasty Balloon's new balloon platform INFINITY Angioplasty Balloon Catheter for percutaneous transluminal angioplasty (PTA) treatment of peripheral arterial disease (PAD).

Therefore, owing to the afore-mentioned factors, the category angioplasty balloon is expected to witness a considerable growth eventually contributing to the overall growth of the global peripheral artery disease (PAD) market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL PERIPHERAL ARTERY DISEASE (PAD) MARKET:

Among all the regions, North America is expected to dominate the global peripheral artery disease (PAD) in the year 2021 and is expected to do the same during the forecast period from 2022-2027.

This can be ascribed to the growing government initiatives to raise awareness regarding effective treatment of peripheral artery diseases, expanding burden of elderly patients prone of various cardiovascular disorders, increasing prevalence of obesity, hypertension, and diabetes, increasing product launches, and the presence of an advanced healthcare facilities in the region, which will boost the peripheral artery disease market in the North America during the forecast period.

For instance, as per the US Census Bureau 2021 report, more than 54 million adults ages 65 and older lived in the United States, in 2021. Further by 2050, the total number of adults ages 65 and older is projected to rise to an estimated 85.7 million roughly 20% of the overall U.S. population. The elderly population especially people above 50 years are more prone to peripheral artery disease.

The increasing prevalence of obesity and overweight will increase the market of peripheral artery disease as obese patients are 3-5 times more likely to develop the most severe complication of PAD. As per the data reported by Centers for Disease Control and Prevention (CDC) 2019, all US states and territories have an obesity rate of at least 20%, in 2019. The source also stated that nearly one out of every three the United States adults is obese.

Moreover, the increasing product launches, approvals, and other regulatory activities among the key players in the region will aid in increasing the demand of the peripheral artery diseases treatment devices and drugs. For instance, in September 2019, Concept Medical received the FDA Breakthrough Therapy designation for its sirolimus-coated balloon catheter developed for treating peripheral artery disease below the knee.

Also, in May 2022, Medtronic, announced approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT™ 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the peripheral artery disease (PAD) market.

PERIPHERAL ARTERY DISEASE (PAD) MARKET KEY PLAYERS:

Some of the key market players operating in the Peripheral Artery Disease (PAD) market includes Medtronic, Otivio., Koninklijke Philips N.V., B. Braun SE, Boston Scientific Corporation, BD., Cook, Bayer AG, Terumo Europe NV, Biotronik, Cardinal Health., Abbott., AngioDynamics., Cardiovascular Systems, Inc., Biosensors International Group, Ltd., Contego Medical, Inc., Cordis., Edwards Lifesciences Corporation., Ra Medical Systems, REX MEDICAL, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN PERIPHERAL ARTERY DISEASE (PAD) MARKET:

  • In June 2020, the US Food and Drug Administration (FDA) had cleared INFINITY Angioplasty Balloon's new balloon platform INFINITY Angioplasty Balloon Catheter for percutaneous transluminal angioplasty (PTA) treatment of peripheral arterial disease (PAD).
  • In September 2020, Abbott Laboratories started the LIFE-BTK clinical trial to assess the effectiveness and safety of its Esprit BTK Everolimus-Eluting Resorbable Scaffold System. This is the Investigational Device Exemption (IDE) trial in the U.S. that is expected to help people battling the advanced stages of peripheral artery disease (PAD).
  • In June 2020, Becton, Dickinson and Company acquired, Straub Medical AG, a private corporation. Medical atherectomy and thrombectomy devices are developed by Straub Medical AG for the treatment of venous and peripheral arterial disorders (PAD).

KEY TAKEAWAYS FROM THE PERIPHERAL ARTERY DISEASE (PAD) MARKET REPORT STUDY

  • Market size analysis for current peripheral artery disease (PAD) market size (2020), and market forecast for 5 years (2021-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the peripheral artery disease (PAD) market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global peripheral artery disease (PAD) market.
  • Various opportunities available for the other competitor in the peripheral artery disease (PAD) market space.
  • What are the top performing segments in 2020? How these segments will perform in 2027.
  • Which is the top-performing regions and countries in the current peripheral artery disease (PAD) market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for peripheral artery disease (PAD) market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS PERIPHERAL ARTERY DISEASE (PAD) MARKET REPORT STUDY

  • Peripheral artery disease (PAD) products providers
  • Research organizations and consulting companies
  • Peripheral artery disease (PAD) -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in peripheral artery disease (PAD)
  • Various end users who want to know more about the peripheral artery disease (PAD) market and latest technological developments in the peripheral artery disease (PAD) market.

FREQUENTLY ASKED QUESTIONS FOR PERIPHERAL ARTERY DISEASE (PAD) MARKET:

1. What is peripheral artery disease (PAD)?

The peripheral artery disease (PAD) is a common cardiovascular condition that is caused by plaque build-up in the arteries, resulting in restricted blood flow to the limbs. Peripheral artery disease is also linked to diabetes, ageing, and high blood pressure.

2. What is the global market for peripheral artery disease (PAD)?

The global peripheral artery disease (PAD) market was valued at USD 3.65 billion in 2021, growing at a CAGR of 8.45% during the forecast period from 2022 to 2027 to reach USD 5.93 billion by 2027.

3. What are the drivers for global peripheral artery disease (PAD) market?

The peripheral artery disease (PAD) market is witnessing a positive market growth owing to the factors such as rising prevalence of peripheral artery disease (PAD) and arteriosclerosis, rising prevalence of obesity, diabetes, and high blood pressure, growing burden of elderly population, rising demand of minimally-invasive procedures, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the peripheral artery disease (PAD) market.

4. Who are the key players operating in the global peripheral artery disease (PAD) market?

Some of the key market players operating in the peripheral artery disease (PAD) market includes Medtronic, Otivio., Koninklijke Philips N.V., B. Braun SE, Boston Scientific Corporation, BD., Cook, Bayer AG, Terumo Europe NV, Biotronik, Cardinal Health., Abbott., AngioDynamics., Cardiovascular Systems, Inc., Biosensors International Group, Ltd., Contego Medical, Inc., Cordis., Edwards Lifesciences Corporation., Ra Medical Systems, REX MEDICAL, and others.

5. Which region has the highest share in peripheral artery disease (PAD) market?

Among all the regions, North America is estimated to amass the significant revenue share in the global peripheral artery disease (PAD) market. This can be ascribed to the growing government initiatives to raise awareness regarding effective treatment of peripheral artery diseases, rising burden of elderly patients, increasing prevalence of obesity, hypertension, and diabetes, the presence of an advanced healthcare facilities in the region, and others acts as a supportive factor for the North America peripheral artery disease (PAD) market growth.

Table of Contents

1. Peripheral Artery Disease (PAD) Market Report Introduction

2. Peripheral Artery Disease (PAD) Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Peripheral Artery Disease (PAD) Market Key Factors Analysis

  • 4.1 Peripheral Artery Disease (PAD) Market Drivers
    • 4.1.1 Rising prevalence of peripheral artery disease (PAD) and arteriosclerosis
    • 4.1.2 Rising prevalence of obesity, diabetes, and high blood pressure
    • 4.1.3 Growing burden of elderly population
    • 4.1.4 Rising demand of minimally-invasive procedures
  • 4.2 Peripheral Artery Disease (PAD) Market Restraints and Challenges
    • 4.2.1 High cost of different devices
    • 4.2.2 Adverse events related to various treatments
  • 4.3 Peripheral Artery Disease (PAD) Market Opportunities
    • 4.3.1 Growing knowledge about the benefits of PAD devices in the market
    • 4.3.2 Growth opportunities in the emerging nation

5. Peripheral Artery Disease (PAD) Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Peripheral Artery Disease (PAD) Market

7. Peripheral Artery Disease (PAD) Market Layout

  • 7.1 By Treatment Type
    • 7.1.1 Devices
      • 7.1.1.1 Angioplasty Balloon
      • 7.1.1.2 Angioplasty Stents
      • 7.1.1.3 Catheters
      • 7.1.1.4 Plaque Modification Devices
      • 7.1.1.5 Hemodynamic Flow Alteration Devices
      • 7.1.1.6 Others
    • 7.1.2 Drugs
  • 7.2 By End-User
    • 7.2.1 Hospitals & Clinics
    • 7.2.2 Ambulatory Surgical Centers
    • 7.2.3 Specialty Clinics
  • 7.3 By Geography
  • 7.3.1 North America
      • 7.3.1.1 United States Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.1.2 Canada Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.1.3 Mexico Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
    • 7.3.2 Europe
      • 7.3.2.1 France Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.2.2 Germany Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.2.3 United Kingdom Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.2.4 Italy Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.2.5 Spain Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.2.6 Rest of Europe Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.3.2 Japan Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.3.3 India Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.3.4 Australia Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.3.5 South Korea Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.3.6 Rest of Asia Pacific Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1. Middle East Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.4.2 Africa Peripheral Artery Disease (PAD) Market in USD million (2019-2027)
      • 7.3.4.3 South America Peripheral Artery Disease (PAD) Market in USD million (2019-2027)

8. Peripheral Artery Disease (PAD) Market Company and Product Profiles

  • 8.1 Medtronic.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4 Product Listing
    • 8.1.5. Entropy
  • 8.2 Otivio.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4 Product Listing
    • 8.2.5. Entropy
  • 8.3 Koninklijke Philips N.V.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4 Product Listing
    • 8.3.5. Entropy
  • 8.4 B. Braun SE
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4 Product Listing
    • 8.4.5. Entropy
  • 8.5 Boston Scientific Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4 Product Listing
    • 8.5.5. Entropy
  • 8.6 BD.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4 Product Listing
    • 8.6.5. Entropy
  • 8.7 Cook
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4 Product Listing
    • 8.7.5. Entropy
  • 8.8 Bayer AG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4 Product Listing
    • 8.8.5. Entropy
  • 8.9 Terumo Europe NV
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4 Product Listing
    • 8.9.5. Entropy
  • 8.10 Biotronik
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4 Product Listing
    • 8.10.5. Entropy
  • 8.11 Cardinal Health.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4 Product Listing
    • 8.11.5. Entropy
  • 8.12 Abbott.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4 Product Listing
    • 8.12.5. Entropy
  • 8.13 AngioDynamics.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4 Product Listing
    • 8.13.5. Entropy
  • 8.14 Cardiovascular Systems, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4 Product Listing
    • 8.14.5. Entropy
  • 8.15 Biosensors International Group, Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4 Product Listing
    • 8.15.5. Entropy
  • 8.16 Contego Medical, Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4 Product Listing
    • 8.16.5. Entropy
  • 8.17 Cordis.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4 Product Listing
    • 8.17.5. Entropy
  • 8.18 Edwards Lifesciences Corporation.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4 Product Listing
    • 8.18.5. Entropy
  • 8.19 Ra Medical Systems
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4 Product Listing
    • 8.19.5. Entropy
  • 8.20 REX MEDICAL
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4 Product Listing
    • 8.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제